A larger body doesn’t necessarily mean you have ‘clinical obesity’, according to a proposed new definition of the disease.

In the pivotal Phase 3 VIVID-1 trial, patients treated with Omvoh experienced significant improvement in clinical remission and endoscopic respons ...

Eli Lilly & Co. Chief Executive Officer Dave Ricks talks about paying $2.5 billion for a cancer drug being developed by Scorpion Therapeutics. He also says Lilly's experimental weight-loss pill could ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

The phrase Make America Great Again doesn’t have to divide us. Let’s reframe it as a challenge to rise to our potential — a call to make Indiana and America a better place for everyone, regardless of ...

Mary Elizabeth Rider, 91, of Greenwood, passed away on January 11, 2025. A native of North Vernon, Indiana, Mary was born on ...

Carlyle Group co-founder and co-chairman and host of "Peer-to-Peer Conversations" David Rubenstein talks about the rising popularity of weight loss drugs and his interview with Eli Lilly CEO Dave ...

Health news updates include the EU contemplating curbs on Chinese medical device makers, Pfizer reducing its stake in Haleon, toothpaste lawsuits over fluoride, Eli Lilly’s stock drop, biopharma ...

Doctors worldwide should diagnose obesity differently, relying on broader criteria and taking into account when the condition ...

Undervalued biotech company Regenxbio Inc. shows promise with cutting-edge gene therapy technology for AMD and MPS II. Click ...

Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research ...

An international and widely supported group of experts is pushing doctors to avoid the exclusive use of BMI to decide whether ...